TICKERNOMICS Sign up
Last Update: 2024-12-27 15:25:14
Bioventus Inc. ( BVS ) https://www.bioventus.com
11.00USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
BVS
105.99%
SPY
32.66%
-20.98%
BVS
SPY
108.59%
BVS
0.00%
SPY
302.52%
BVS
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
696.96
1037.47
0.26
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-17.65
1.26
3.73
4.05
0.00
497.35
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
2.93
67.32
0.37
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
2.28
-1.87
0.00
Other Earnings and Cash Flow Stats:
Bioventus Inc. ( BVS ) Net Income TTM ($MM) is -39.48
Bioventus Inc. ( BVS ) Operating Income TTM ($MM) is -15.71
Bioventus Inc. ( BVS ) Owners' Earnings Annual ($MM) is 0.00
Bioventus Inc. ( BVS ) Current Price to Owners' Earnings ratio is 0.00
Bioventus Inc. ( BVS ) EBITDA TTM ($MM) is 12.67
Bioventus Inc. ( BVS ) EBITDA Margin is 0.37%
Capital Allocation:
Bioventus Inc. ( BVS ) has paid 0.00 dividends per share and bought back -2.434109 million shares in the past 12 months
Bioventus Inc. ( BVS ) has reduced its debt by 11.03 million USD in the last 12 months
Capital Structure:
Bioventus Inc. ( BVS ) Interest-bearing Debt ($MM) as of last quarter is 383
Bioventus Inc. ( BVS ) Annual Working Capital Investments ($MM) are -4
Bioventus Inc. ( BVS ) Book Value ($MM) as of last quarter is 186
Bioventus Inc. ( BVS ) Debt/Capital as of last quarter is 257%
Other Balance Sheet Stats:
Bioventus Inc. ( BVS ) has 43 million in cash on hand as of last quarter
Bioventus Inc. ( BVS ) has 211 million of liabilities due within 12 months, and long term debt 383 as of last quarter
Bioventus Inc. ( BVS ) has 65 common shares outstanding as of last quarter
Bioventus Inc. ( BVS ) has 0 million USD of preferred stock value
Academic Scores:
Bioventus Inc. ( BVS ) Altman Z-Score is 0.87 as of last quarter
Bioventus Inc. ( BVS ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
Bioventus Inc. ( BVS ) largest shareholder is owning shares at 0.00 ($MM) value
Bartholdson John A.(an insider) Bought 25500 shares of Bioventus Inc. ( BVS ) for the amount of $217966.35 on 2024-08-19
11.48% of Bioventus Inc. ( BVS ) is held by insiders, and 69.80% is held by institutions
Bioventus Inc. ( BVS ) went public on 2021-02-11
Other Bioventus Inc. ( BVS ) financial metrics:
FCF:29.65
Unlevered Free Cash Flow:0.00
EPS:-0.30
Operating Margin:2.93
Gross Profit Margin:67.32
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-12.97
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Bioventus Inc. ( BVS ) :
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for precise bone sculpting, removing tumors, and tissue debridement. The company's restorative therapies include a bone healing system; skin allografts; and products that are used to support healing of wounds, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.